The effectiveness of xylocaine spray in upper gastrointestinal endoscopy
The effect of 10% xylocaine spray compared to a placebo on ease of endoscopy and hemodynamic changes in patients admitted for upper gastrointestinal endoscopy under deep sedation with total intravenous anesthesia
Chang Gung Memorial Hospital
150 participants
Dec 25, 2010
Interventional
Conditions
Summary
The use of topical pharyngeal anesthesia has long been controversial among the anesthetists and no evidence has well supported the use of the spray. The use of lidocaine spray is not without adverse effects, which include aspiration pneumonia, methemoglobinemia and anaphylaxis. Most of the patients undergo endoscopies under general anesthesia and theoretically should not require pharngeal spray to suppress pharyngeal reflexes during the procedure. The aim of the study is determine whether the use of the spray is necessary in patients under deep sedation/general anesthesia. Deep sedation is achieved by total intravenous anesthesia (TIVA) with propofol.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients are randomly assigned to have 10% lidocaine spray (approximately 30mg) or normal saline in their throat on arrival, approximately 3 minutes before upper gastrointestinal endoscopy.
Locations(2)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12611000143921